ADMA Biologics 대차 대조표 상태
재무 상태 기준 확인 6/6
ADMA Biologics 의 총 주주 지분은 $231.9M 이고 총 부채는 $101.3M, 이는 부채 대 자기자본 비율을 43.7% 로 가져옵니다. 총자산과 총부채는 각각 $390.6M 및 $158.7M 입니다. ADMA Biologics 의 EBIT는 $117.7M 이며 이자보상배율은 7.8 입니다. $86.7M 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
43.7%
부채 비율
US$101.33m
부채
| 이자 보상 비율 | 7.8x |
| 현금 | US$86.71m |
| 주식 | US$231.89m |
| 총 부채 | US$158.73m |
| 총 자산 | US$390.62m |
최근 재무 상태 업데이트
Is ADMA Biologics (NASDAQ:ADMA) Using Too Much Debt?
Jul 17
Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?
Apr 04We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt
Oct 25We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt
Jun 10ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt
Jun 01Recent updates
ADMA Biologics, Inc.'s (NASDAQ:ADMA) 27% Price Boost Is Out Of Tune With Revenues
Oct 09ADMA Biologics: Riding High On ASCENIV's Success
Oct 02ADMA Biologics, Inc.'s (NASDAQ:ADMA) Intrinsic Value Is Potentially 57% Above Its Share Price
Sep 06ADMA Biologics' (NASDAQ:ADMA) Strong Earnings Are Of Good Quality
Aug 16ADMA Biologics: A Compelling GARP Stock For Biotech Investors
Jul 27ADMA Biologics, Inc. (NASDAQ:ADMA) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Jul 24Is ADMA Biologics (NASDAQ:ADMA) Using Too Much Debt?
Jul 17Is ADMA Biologics, Inc. (NASDAQ:ADMA) Trading At A 43% Discount?
May 30ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next
May 13Giving ADMA Biologics A Well-Deserved 'Booyah'
May 12ADMA Biologics, Inc.'s (NASDAQ:ADMA) Prospects Need A Boost To Lift Shares
May 08Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?
Apr 04Rising Margins And Product Promise Drive ADMA Biologics Forward (Rating Upgrade)
Apr 03ADMA Biologics: On A Roll Entering 2024
Jan 19Is There An Opportunity With ADMA Biologics, Inc.'s (NASDAQ:ADMA) 50% Undervaluation?
Jan 09ADMA Biologics, Inc. (NASDAQ:ADMA) Surges 30% Yet Its Low P/S Is No Reason For Excitement
Jan 09We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt
Oct 25We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt
Jun 10The Market Doesn't Like What It Sees From ADMA Biologics, Inc.'s (NASDAQ:ADMA) Revenues Yet
May 12ADMA Biologics: Strong Growth Is Clearing The Path To Profitability
Aug 21ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M
Aug 10ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt
Jun 01ADMA Biologics: A Path To Profits Looks Clear
May 12ADMA: Pertinent Updates
Apr 18ADMA Biologics' 2021 Numbers Showed Continued Strong Execution
Mar 29ADMA Biologics: 2021 Was Tough
Jan 18재무 상태 분석
단기부채: ADMA 의 단기 자산 ( $318.2M )이 단기 부채( $44.9M ).
장기 부채: ADMA 의 단기 자산( $318.2M )이 장기 부채( $113.8M ).
부채 대 자본 내역 및 분석
부채 수준: ADMA 의 순부채 대 자기자본 비율( 6.3% )은 satisfactory로 간주됩니다.
부채 감소: ADMA 의 부채 대 자기자본 비율은 지난 5년간 229.1% 에서 43.7% 로 감소했습니다.
부채 범위: ADMA 의 부채는 영업 현금 흐름 ( 84.9% )에 의해 잘 충당되었습니다.
이자 보장: ADMA 의 부채에 대한 이자 지급은 EBIT( 7.8 x 적용 범위)로 잘 충당됩니다.